BRAF and neoplasm: Overall, 14 out of 25 studies scored cases positive for BRAF V600E mutation when uniform or nearly uniform, diffuse staining was present in tumor cells or when the majority (≥ 75%) of tumor cells exhibited unequivocal cytoplasmic staining (Table 2).